Deciphera Pharmaceuticals Inc (NASDAQ:DCPH)
| 11.85 Delayed Data As of May 20 |  +0.48 / +4.22%Today’s Change | 6.51 Today|||52-Week Range 38.91 | +21.29% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Brightstar Associates Llc |  Buy | 4/29/2022 | 1,478,978 | $10.00 | $14.8M | +17.00% |
Sherman Matthew L Chief Medical Officer & Executive Vice President |  Sale | 10/04/2021 | 2,659 | $33.17 | $88.2K | -64.20% |
Hoerter Steven L President & Chief Executive Officer | Sale | 3/21/2022 | 3,150 | $9.11 | $28.7K | +33.48% |
Kelly Thomas P Chief Financial Officer | Sale | 2/16/2022 | 1,368 | $9.05 | $12.4K | +31.56% |
Flynn Daniel L Chief Scientific Officer | Sale | 2/16/2022 | 1,366 | $9.05 | $12.4K | +31.56% |
Pitman Jama Corporate Officer | Sale | 2/16/2022 | 1,146 | $9.05 | $10.4K | +31.56% |
Martin Daniel C Chief Commercial Officer | Sale | 2/16/2022 | 1,146 | $9.05 | $10.4K | +31.56% |
Sherman Matthew L Chief Medical Officer & Executive Vice President | Sale | 2/16/2022 | 984 | $9.05 | $8.9K | +31.56% |
Martin Daniel C Chief Commercial Officer | Gift | 12/15/2021 | 8,300 | $0.00 | $0.00 | +28.28% |
Flynn Daniel L Chief Scientific Officer | Gift | 12/15/2021 | 11,100 | $0.00 | $0.00 | +28.28% |
Page of 2